The US FDA would become more involved in pharmaceutical manufacturing business continuity planning under several legislative proposals outlined in the agency’s fiscal year 2020 budget request.
FDA Aims For Greater Role In Pharma Business Continuity Planning
Legislative proposals described in the US FDA’s FY 2020 budget request justification document would give the agency more authority to oversee business continuity planning at pharmaceutical companies with the idea of preventing shortages of essential drugs.
